ReWrite SRL
The score of ReWrite shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ReWrite's annual accounts
| 2025 | |
|---|---|
| Net result | −17,869 € |
| Equity | −2,869 € |
| Cash | 44,086 € |
| EBITDA | −14,377 € |
| Total assets | 115,374 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
ReWrite's financial analysis
- Solvency-2.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ReWrite
ReWrite's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.891.283
- VAT number
- BE1016891283
- Peppol
- Registered · 0208:1016891283 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Dec 2024
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
ReWrite (SRL) has been based in Leuven since 2024, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 17,869 € and equity of −2,869 €; its revenue is not published. Its solvency stands at -2.5%, below the median of its sector (60.4%).
Companies similar to ReWrite
Companies in the same business, of comparable size and area, outside its group.
- FoxBioPath Research and experimental development on natural sciences and engineering Duffel · balance sheet 103,842 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Aquature Technologies Research and experimental development on natural sciences and engineering Antwerp · balance sheet 122,734 €
- Consultbio Research and experimental development on natural sciences and engineering Rumst · balance sheet 106,674 €
- Bio-Perspectives Research and experimental development on natural sciences and engineering Ixelles · balance sheet 206,760 €
- Clino Consult Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 191,749 €
- Elandd Research and experimental development on natural sciences and engineering Bonheiden · balance sheet 129,408 €
- LP Engineering Research and experimental development on natural sciences and engineering Liège · balance sheet 138,903 €
Frequently asked questions about ReWrite
What is the revenue of ReWrite?
ReWrite files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ReWrite?
In Belgium, the VAT number is the company number prefixed with BE: BE1016891283 for ReWrite, if the company is VAT-registered. Its company number (CBE) is 1016.891.283.
Where is the registered office of ReWrite?
According to the CBE register, the registered office of ReWrite is in 3001 Leuven.
What is the equity of ReWrite?
At the close of the 2025 financial year, the equity of ReWrite amounts to -2,869 €, a solvency of -2.5% of total assets.
Who manages ReWrite?
The register lists 1 active mandates at ReWrite. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ReWrite
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →